Neel Reddy

Neel Reddy


Dr. Whitney Woodmansee


College of Medicine




Business Administration


American Medical Students Association (AMSA)

Academic Awards



Shands Emergency Department Volunteer

Research Interests

My research interests are held in a wide variety of specialties in the sciences and humanities. I have partaken in research in health disparities while focusing on the impact of social determinants within my community. My current primary research interest is in the area of hyperthyroidism and thyroid-related diseases. I aspire to develop my knowledge of pituitary disorders by studying the progression and treatment of commonly presented disorders.

Hobbies and Interests

In my free time, I enjoy playing Hockey and going to the gym with my friends. I also play the Piano and enjoy traveling to new places.

Research Project

Assessment of the 2016 American Thyroid Association Hyperthyroidism Clinical Guidelines on Treatment of Subclinical Hyperthyroidism among Clinicians

Hyperthyroidism is characterized by increased thyroid hormone synthesis and secretion from the thyroid gland. Subclinical Hyperthyroidism is a mild form of hyperthyroidism that is defined by a low or undetectable serum thyroid-stimulating hormone (TSH) level, with normal free thyroxine (T4) and total or free triiodothyronine (T3) levels. The prevalence of hyperthyroidism in the US population is about 1.2% (0.5% overt and 0.7% subclinical). Subclinical hyperthyroidism is associated with impaired quality of life and hyperthyroid symptoms, as well as increased risk of bone loss and atrial fibrillation.

A study was undertaken in 2003 to understand management strategies at the time in the absence of clinical guidelines. A confidential clinical survey was mailed to 300 physician members in the American Thyroid Association (ATA) to assess their views on the management of subclinical hyperthyroidism using a variety of clinical scenarios.  These scenarios included older vs. younger patients and those with mild vs. more severe subclinical hyperthyroidism as determined by the degree of TSH suppression. Respondents showed that they were more likely to recommend additional testing in patients with undetectable TSH values compared to patients with only slightly suppressed values. Additionally, antithyroid drugs were commonly prescribed as a treatment option amongst others such as Beta Blockers and surgery. In 2016, the ATA released guidelines for the diagnosis and management of subclinical hyperthyroidism. These guidelines presented additional treatment requirements and management options for patients with hyperthyroidism.

The central goal of this project is to repeat the prior clinical survey of ATA members to determine if the 2016 guidelines impacted clinical practice and to assess the practice patterns in general medicine providers. More specifically, to determine if any shift in treatment of subclinical hyperthyroidism was recorded among thyroid specialists and to compare practice patterns of Thyroid specialists to general practitioners.